Gluskin Sheff + Associates Inc. news

   Watch this stock
Showing stories 1 - 10 of about 29   

Articles published

GS 28.09 -0.27 (-0.95%)
price chart
Gluskin Sheff + Associates Inc. announces results of its annual meeting of ...
6, 2014 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") reported the results of its Annual Meeting of the Company's shareholders held earlier today (the "Meeting").
Gluskin Sheff + Associates Inc. declares regular quarterly dividend of $0.225  iStockAnalyst (press release)
Gluskin Sheff + Associates Inc. (GS) Plans Quarterly Dividend of C$0.23  Ticker Report
Related articles »  
Gluskin Sheff + Associates PT Raised to C$36.00 (GS)
Gluskin Sheff + Associates Inc. logo Equities research analysts at TD Securities raised their price target on shares of Gluskin Sheff + Associates (TSE:GS) from C$35.00 to C$36.00 in a research note issued to investors on Friday. The firm currently has ...
National Bank Financial Cuts Gluskin Sheff + Associates Price Target to C$36 ...  WKRB News
Related articles »  
Gluskin Sheff + Associates Receives Average Rating of "Buy" from Analysts (TSE ...
Gluskin Sheff + Associates Inc (TSE:GS) is a wealth management company. Receive News & Ratings for Gluskin Sheff + Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gluskin ...
Top Links: Two good reasons for market optimism  The Globe and Mail
Related articles »  
Gluskin Sheff + Associates PT Raised to C$36.00 at TD Securities (GS)
Gluskin Sheff + Associates Inc. logo Equities research analysts at TD Securities increased their price target on shares of Gluskin Sheff + Associates (TSE:GS) from C$35.00 to C$36.00 in a research note issued to investors on Friday. The firm currently ...
Related articles »  
Gluskin Sheff + Associates Given Consensus Recommendation of "Buy" by ...
Gluskin Sheff + Associates Inc (TSE:GS) is a wealth management company. Receive News & Ratings for Gluskin Sheff + Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gluskin ...
Gluskin Sheff + Associates Given Average Rating of "Buy" by Brokerages (TSE:GS)
Finally, analysts at Scotiabank reiterated a �sector perform� rating on shares of Gluskin Sheff + Associates in a research note on Friday, September 19th.
Fund managers stay healthy despite market volatility
Mr. Kwan also includes Gluskin Sheff + Associates Inc. and IGM Financial Inc. as top picks. �Gluskin Sheff has the best fundamentals versus peers; exposure to performance-fee driven special dividends; and is our top long-term growth potential name ...
Oil price drop equivalent to a $40-billion tax cut, so stop moaning, says ...
... energy prices are a bad thing and that the commensurate decline in inflation expectations is something that should be giving the Fed a lot to be concerned about,� the chief economist and strategist at Gluskin Sheff + Associates Inc. said in a note ...
Valeant left out as Actavis buys Allergan
This may have been a mistake from Valeant's perspective, said Peter Mann, managing director and portfolio manager at Gluskin Sheff + Associates, which holds shares of both Valeant and Allergan. "The fact that (Valeant) combined with an activist ...
Valeant left out in the cold as Actavis buys Allergan for $66-billion, but ...
This may have been a mistake from Valeant's perspective, said Peter Mann, managing director and portfolio manager at Gluskin Sheff + Associates, which holds shares of both Valeant and Allergan. �The fact that [Valeant] combined with an activist ...
Losing Allergan deals blow to Valeant reputation  Interactive Investor
Related articles »